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Sphingosine-1-phosphate 1 receptorEndoderm development is dependent on inductive signals from different structures in close vicinity, including
the notochord, lateral plate mesoderm and endothelial cells. Recently, we demonstrated that a functional
vascular system is necessary for proper pancreas development, and that sphingosine-1-phosphate (S1P)
exhibits the traits of a blood vessel-derived molecule involved in early pancreas morphogenesis. To examine
whether S1P1-signaling plays a more general role in endoderm development, S1P1-deﬁcient mice were
analyzed. S1P1 ablation results in compromised growth of several foregut-derived organs, including the
stomach, dorsal and ventral pancreas and liver. Within the developing pancreas the reduction in organ size
was due to deﬁcient proliferation of Pdx1+ pancreatic progenitors, whereas endocrine cell differentiation was
unaffected. Ablation of endothelial cells in vitro did not mimic the S1P1 phenotype, instead, increased organ
size and hyperbranching were observed. Consistent with a negative role for endothelial cells in endoderm
organ expansion, excessive vasculature was discovered in S1P1-deﬁcient embryos. Altogether, our results
show that endothelial cell hyperplasia negatively inﬂuences organ development in several foregut-derived
organs.ment of Laboratory Medicine,
den. Fax: +46 46 2223600.
er Research, Department of
nburg, Gula Stråket 8, SE-413
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Organ and vascular development are an interdependent processes
where cross talk between blood vessels and the developing organ
anlagen regulates proper organ architecture and function. In the
present investigation the effect of a perturbed vascular system on the
development of foregut-derived organs was studied in sphingosine-1-
phosphate receptor 1 (S1P1) deﬁcient embryos.
S1P1 is a G-coupled receptor and is the founding member of a
family of ﬁve receptors, S1P1–5, formerly known as EDG receptors.
S1P1's ligand, sphingosine-1-phosphate (S1P), is a bioactive lipid
found at high concentrations in the blood stream where it binds to
albumin and high density lipoprotein (HDL). Blood-born S1P is
produced and secreted by red blood cells, platelets, monocytes, mast
cells, and possibly endothelial cells (Pappu et al., 2007; Venkataramanet al., 2008; Yatomi et al., 1995). In the surrounding tissues S1P is
found at lower levels due to degradation by S1P lyase (Schwab et al.,
2005). The conserved and ubiquitously expressed enzymes sphingo-
sine kinase 1 (SphK1) and 2 synthesize S1P by phosphorylation of
sphingosine (Spiegel and Milstien, 2002). Upon receptor binding
S1P mediates cell proliferation (Zhang et al., 1991), survival (Paris
et al., 2002), migration (Sadahira et al., 1992), and morphogenesis
(Kupperman et al., 2000). S1P1–3 are widely expressed whereas S1P4
is expressed in lymphoid tissues and S1P5 in the central nervous
system and spleen. S1P1–3 play critical roles in vascular maturation.
For example, ablating S1P1 in mice results in massive hemorrhages
and destabilization of blood vessels causing lethality before E14.5
(Kono et al., 2004; Liu et al., 2000).
The deﬁnitive endoderm gives rise to a number of organs along the
primitive gut tube, including the pharynx, thyroid, parathyroid,
esophagus, lungs, thymus, stomach, liver, pancreas, small and large
intestine. Endoderm development involves axis formation, induction,
expansion and differentiation/maturation. Signals from mesoder-
mally-derived tissues in close vicinity to the endoderm, such as the
notochord, heart, splanchnic mesenchyme and endothelium, control
many aspects of these processes (Deutsch et al., 2001; Golosow and
Grobstein, 1962; Hebrok et al., 1998; Kim et al., 1997; Lammert et al.,
2001; Wessells and Cohen, 1967; Yoshitomi and Zaret, 2004).
Fig. 1. S1P1 is expressed by endothelial cells within the mesenchyme. Immunoﬂuo-
rescence was used to investigate S1P1 expression within the embryonic primitive gut
tube and its later derived organs. S1P1 (red), co-expressed with Pecam positive blood
vessels (blue). The endoderm is visualized by Ecad (green). The inset in (A) shows Pdx1
(red) in the part of the endoderm (green), which represents the dorsal pancreas.
Throughout the early phase of endodermal development S1P1 expression can be
detected in blood vessels, neural ectoderm and blood cells. Between E9 and E12 the
dorsal pancreas is separated from the S1P1+ dorsal aorta by the invading mesenchyme.
The mesenchyme is inﬁltrated by S1P1+ blood vessels that reestablish the endoderm–
endothelial interaction (C). E12.5 S1P1 expressing blood vessels are found in the
mesenchyme surrounding both the lung (E) and stomach (B) epithelium as well as in
the blood vessels of the liver (D). Dorsal pancreas (dp) and dorsal aorta (da). Scale bars
100 μm.
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endoderm mediates the induction of several organ primordia along
the anterior–posterior axis of the gut tube. Furthermore, mesenchyme
to endoderm signaling, via FGF10, plays a central role in the
proliferation of progenitors within the thyroid, thymus, lung, liver,
pancreas, stomach and caecum (Berg et al., 2007; Bhushan et al., 2001;
Burns et al., 2004; Min et al., 1998; Nyeng et al., 2007; Ohuchi et al.,
2000; Revest et al., 2001; Sekine et al., 1999). These observationswere
recently supported by genetic evidence, demonstrating that failure to
form the dorsal pancreatic mesenchyme in Isl1-, N-cadherin- and
Raldh2-ablated embryos results in dorsal pancreatic agenesis (Ahlgren
et al., 1997; Esni et al., 2001; Martin et al., 2005).
Endothelial cells inﬂuence liver development already when the
hepatic cells inﬁltrate the septum transversum before vascular
function (Matsumoto et al., 2001). Furthermore, increased liver
vasculature results in hyperplasia of the liver due to paracrine factors
(LeCouter et al., 2003). In vitro culturing of lung rudiments under
hypoxic conditions leads to augmented vessel density and reduced
lung epithelial branching.Moreover, over expression of VEGF A in vivo
results in increased vascular density and reduced branching of the
lung epithelium (Akeson et al., 2003; Zeng et al., 1998). During
pancreas development initiation of the dorsal pancreatic bud,
maintenance of expression of the crucial pancreatic and duodenal
homeobox 1 (Pdx1) transcription factor, induction of the pancreas
speciﬁc transcription factor 1a (Ptf1a) and endocrine cell speciﬁcation
also depend on endothelial signals (Lammert et al., 2001; Yoshitomi
and Zaret, 2004). In contrast, endothelial cells are not necessary for
similar events in the ventral bud (Yoshitomi and Zaret, 2004).
Endoderm–endothelial interactions continue after themesenchyme is
inﬁltrated by blood vessels. For example, over expression of VEGF A
under the control of the Pdx1 promoter expands the endocrine
compartment, whereas the acinar compartment is reduced, suggest-
ing that endocrine and exocrine cell differentiation is controlled by
the vasculature. Taken together these data clearly illustrate the
importance of well-balanced interactions between the mesenchyme
and endothelium with the endoderm for proper induction and
expansion of gut-derived organs.
The vasculature signals both via endothelial cells and its content.
Recently, we have showed that a functional vascular system plays an
important role in dorsal pancreas development by supplying signaling
cues from the circulation, and in particular through S1P (Edsbagge
et al., 2005).
To directly address the functional role of S1P signaling within
endothelial cells during endoderm development, S1P1 deﬁcient
embryos were analyzed. Here, we demonstrate that S1P1, which is
speciﬁcally expressed in the endothelium, is required for growth of
several foregut derivatives, including stomach, dorsal and ventral
pancreas, and liver. We also show that growth of the pancreatic
endoderm requires S1P1 function, and that reduction in pancreatic
volume is caused by a decrease in progenitor proliferation. However,
endocrine cell differentiation was unaffected. We were also able to
reproduce these results in vitro, thereby excluding indirect effects via
changes in the supply of oxygen and nutrients. Surprisingly,
endothelial cell ablation failed to mimic the S1P1 phenotype. Instead,
increased pancreatic organ size and hyper branching were observed.
Together with the observation of increased number of endothelial
cells in S1P1-deﬁcient embryos, these results point towards a hitherto
unknown concept of endothelial cells limiting expansion of foregut-
derived organs.
Results
S1P1 is expressed in endothelial cells during embryogenesis
To determine the S1P1 protein expression proﬁle in the developing
endoderm, triple immunoﬂuorescence labeling of E-cadherin (Ecad),S1P1 and Pecam was conducted. S1P1 speciﬁcally co-localized with
Pecam in endothelial cells at E9.5 and E12.5 (Fig. 1 and S1). During
early stages (E9.5) the gut endoderm is primarily exposed to
endothelial cells in the form of the dorsal aorta (Fig. 1A), whereas
the various endoderm-derived organ anlagen later interact with
endothelial cells within the surrounding splanchnic mesenchyme
(Figs. 1B–E). S1P1 expression was also detected in the central nervous
system, but not within the endoderm (Fig. 1 and data not shown).
Growth of foregut-derived organ primordia is compromised in
S1P1-deﬁcient embryos
To determine the functional role of S1P1 during foregut endoderm
development, the epithelial volume of various foregut-derived organ
anlagen was measured using Optical Projection Tomography (OPT).
Consistent with the original observation, S1P1-deﬁcient embryos died
before E14.5 due to cardiovascular defects (Liu et al., 2000). Although
the size of the embryos was not severely affected at E12.5,
hemorrhages within the central nervous system and the limb buds
were observed (Figs. 2A–B). Several of the foregut-derived organs
were affected in the S1P1 mutants (Figs. 2C–D). Besides, the
expression levels of Ecad increased along the anterior–posterior axis
of the foregut endoderm. For example, Ecad expression was higher in
Fig. 2. Quantiﬁcation of endoderm volumes at E12.5. The S1P1 deﬁcient embryos suffer from hemorrhages in the central nervous system and in the shortened extremities (A–B). As
reported earlier the overall size of the embryos was not severely affected at E12.5. Several foregut-derived organs were affected by S1P1 ablation (C–D). The dorsal pancreatic bud
from S1P1 deﬁcient embryos protrudes shorter from the duodenum compared to littermate controls (C–D). Note the difference in Ecad intensity between the endoderm organs, with
intense Ecad signal in the pancreatic buds, whereas less signal was detected within the lungs. The volume of the endoderm organs; lung, dorsal and ventral pancreas and stomach
from S1P1 deﬁcient embryos was quantiﬁed using OPT (E–P). The volume of the S1P1 deﬁcient dorsal (32%) and ventral (45%) pancreata and stomach (32%), as analyzed by OPT, is
signiﬁcantly reduced compared to the littermate controls (M, P, J), whereas the lung was reduced by 30% but did not reach signiﬁcance (G). All images are isosurface renderings
based on the signal fromEcad stainings. The volume of the liverwas quantiﬁed usingOPT based on endogenous autoﬂuorescence (Q–S). The liver volumewas reduced by 61% (S). In order
to investigate if S1P1 ablation resulted inmorphological changes in themesenchyme surrounding the endoderm, a cutting plane was placed in the autoﬂuorescence channel whereas the
Ecad channelwas keep intact. This analysis revealedno dramatic change in the organization of themesenchyme surrounding the dorsal pancreas (T–U). Scale bars are 100 μmin all except
A–D andQ–Rwhere they are 500 μm. InG, J,M, P and S S1P1−/− is compared to S1P1+/+and+/−with Student T-test. Lung comparison, p=0.0989, dorsal bud comparison, p=0.0296,
ventral comparison, p=0.0334, stomach comparison, p=0.0239 and liver comparison, p=0.0003. Error bars represent±SEM. S1P1−/− n=6 and S1P1+/− n=8. Lu = lung, Es =
esophagus, St = stomach, Dp = dorsal pancreas, Vp = ventral pancreas and Du = duodenum.
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expression levels of Ecad might be due to the fact that lung is a much
more branched and tubular organ at this time point, compared to the
pancreas. OPT analysis demonstrated that the dorsal (Figs. 2K–M) and
ventral (Figs. 2N–P) pancreas and the stomach (Figs. 2H–J) were
signiﬁcantly reduced in size in S1P1−/− embryos. The dorsal pancreas
was, on average, reduced by 32%, the ventral pancreas by 45% and the
stomach by 32%. As a result, the protrusion of the S1P1−/− dorsal
pancreatic bud was reduced (Figs. 2C–D). The lung (Figs. 2E–G, and
data not shown) showed a similar trend in size reduction (30%)together with a decline in distal tip number. However, these changes
were not statistically signiﬁcant. For liver volume analyses the high
endogenous autoﬂuorescence precluded the use of Ecad stainings.
Instead, OPT measurements of the liver volumes are based on
endogenous autoﬂuorescence and demonstrated a 61% reduction
(Figs. 2Q–S). For an overview of all the organs included in the data set
see Supplementary Figs. S2A–B.
To address if S1P1 ablation resulted in morphological changes in
the surrounding endodermal mesenchyme, a cutting planewas placed
in the autoﬂuorescence channel with the Ecad channel being kept
270 F.W. Sand et al. / Developmental Biology 352 (2011) 267–277intact. This analysis revealed no dramatic changes in the organization
of the mesenchyme surrounding the dorsal pancreas (Fig. 2T–U and
Supplementary Videos 1–2).
To investigate the onset of perturbed expansion of pancreatic
endoderm in S1P1−/− embryos, quantiﬁcation of the dorsal pancre-
atic volume was conducted by whole mount E-cadherin stainings.
Whereas no difference in the size of the dorsal pancreas was found at
E10.5 (Figs. 3A–C), at E11.5 a 23% reduction was observed in S1P1
mutants, compared to controls (Figs. 3D–F).
The functional role of S1P1 in expansion of the pancreatic endoderm is
independent of circulatory factors
To further resolve how S1P1 may control expansion of foregut
endoderm derivatives, we focused on one particular foregut-derived
organ, i.e. the pancreas. To eliminate the possibility that the
endodermal phenotype observed in S1P1-deﬁcient embryos was
caused by defective circulation, development of the pancreatic
endoderm was studied in vitro. At E11.5, no obvious morphological
or embryo survival differences were observed between S1P1−/−
embryos and their litter mate controls (insets in Figs. 4A–B) (Liu et al.,
2000). However, although control explants consistently developed
normally (27 out of 30), the phenotype of the S1P1−/− explants was
rather diverse, spanning from severely compromised growth to
merely a reduction in size and degree of branching (Figs. 4A–C
and S3A–F). In fact, a high percentage (25%) of the S1P1-deﬁcient
explants did not grow at all (Fig. 4C). Even when the more naïve
pancreatic endoderm was analyzed in vitro similar observations were
made. Speciﬁcally, analysis of E9.5 S1P1 mutant explants cultured in
vitro for 4 days (corresponding to E11.5–12.5 in vivo), revealed
aberrant development of the pancreatic endoderm (Figs. 4D–F).
S1P1 is required for proliferation of Pdx1
+ pancreatic progenitors but
dispensable for endocrine differentiation
To test if the observed defective growth of the epithelium involved
changes in cell proliferation, sections from E12.5 BrdU-pulsed
embryos were stained for Pdx1 and BrdU. Proliferating cells were
observed in both the pancreatic mesenchyme and epithelium, in both
genotypes (Figs. 5A–B). However, the proliferative rate of Pdx1+ cellsFig. 3. The S1P1 endodermal phenotype is detectable at E11.5. To investigate how early the S
after confocal analysis. At E11.5 a reduction of the mutant dorsal pancreatic volume by 23% c
pancreas. Scale bars 100 μm.was signiﬁcantly lower in S1P1-deﬁcient embryos compared to their
littermate control embryos (Fig. 5C).
Caspase 3 staining of E12.5 dorsal pancreas revealed insigniﬁcant
apoptotic activities in control and S1P1-deﬁcient embryos, thus
excluding apoptosis as an explanation for how S1P1 signaling controls
pancreatic endoderm expansion (Fig. S4). To examine whether
necrosis was increased in S1P1-deﬁcient embryos, expression of the
inﬂammatory marker CD45 was investigated. An increase in CD45+
cells within the epithelium would indicate ongoing inﬂammation and
necrosis. However, no increase in the relative number of CD45+ cells
was found (Fig. S4). Altogether, these data suggests that reduced cell
proliferation, but not an increase in apoptosis or necrosis, explains the
reduced organ size in S1P1-deﬁcient embryos.
At E12.5, glucagon+ cells are the most abundant hormone-
producing cell type in the dorsal pancreas. To investigate if endocrine
differentiation relies on S1P1 function, whole mount staining of the
dorsal pancreatic bud for Ecad and glucagon were conducted
(Fig. 5D). At E12.5, S1P1 deﬁciency resulted in no signiﬁcant change
in alpha cell differentiation compared to the littermate controls
(Fig. 5E). Notably, confocal measurements of the epithelial volume
matched our OPT ﬁndings (Fig. 5F). To address if beta cell
differentiation was affected, E11.5 explants were cultured for two
days and analyzed by whole mount staining using insulin and E-
cadherin antibodies (Fig. 5G). Consistent with the in vivo analysis, in
vitro culture of the dorsal pancreas resulted in reduced volume of the
mutantdorsal pancreas (Fig. 5I). However, S1P1deﬁciency resulted inno
signiﬁcant change in the relative number of insulin+ cells (5H). QPCR
analysis of E12.5 dorsal pancreatic buds was in line with these
observations, which demonstrated that Ngn3, Pax4 and 6, Pdx1 and
insulinmRNA expression was unchanged in S1P1 mutants (Figs. 5K–O).
QPCR analysis of the markers for various progenitor populations,
including Cpa1 (tip cells at E12.5 and later acinar cells) (Zhou et al.,
2007), Sox9 (multipotent progenitors at E12.5 and later ducts)
(Seymour et al., 2007) as well as the acinar marker amylase revealed,
no statistical change in the relative mRNA expression (Figs. 5P–R).
Furthermore, an analysis of the distribution of the lumenal marker,
Mucin1, revealed that the overall luminal network in the S1P1−/−
dorsal bud was comparable to the controls (Fig. 5J). However, the
proximal part of the S1P1−/− pancreatic duct was slightly less
branched, which probably is secondary to the overall reduction in
organ size.1P1 endodermal phenotype could be detected dorsal pancreatic volume was measured
ould be detected (D–F) but not at E10.5 (A–C). Dp = dorsal pancreas and Vp = ventral
Fig. 4. In vitro culture of E9.5 and E11.5 S1P1-deﬁcient pancreatic explants fails to rescue the phenotype. To conﬁrm the reduced growth seen in vivo cultures of E11.5 explanted gut
tubes were carried out in vitro. Immunoﬂuorescence analysis of the epithelial marker Ecad (red) concluded that in vitro culture of S1P1 deﬁcient explants is not sufﬁcient to rescue
the pancreatic phenotype (A–C), as insets in A and B the embryos are shown. S1P1+/+ littermate controls n=8, +/− n=22, and−/− n=12. To verify that the endoderm had not
been permanently damaged already at E11.5, E9.5 cultures were also carried out, Ecad (red) and Pdx1 (green). Even though the success rate in littermate controls was slightly lower,
the S1P1 mutant explants developed notably worse (D–F). S1P1+/+ littermate controls n=3, +/− n=5, and−/− n=6. These data support the hypothesis that the phenotype is
not just secondary to the cardio-vascular phenotype. Scale bars 100 μm. The explants shown in A–B are also included in the volume quantiﬁcation in Fig. 5H.
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progenitors, but not for early endocrine and exocrine cell speciﬁcation.
Gene expression analysis of the E10.5 S1P1−/− dorsal pancreas
To mechanistically dissect the role of S1P1 in pancreas develop-
ment we ﬁrst examined the mRNA expression levels of genes known
to control endoderm development. Ptf1a controls dorsal pancreas
speciﬁcation and is expressed in multipotent progenitors but later
becomes restricted to acinar cells (Krapp et al., 1996; Yoshitomi and
Zaret, 2004). S1P1 ablation resulted in no change in the mRNA and
protein expression of Ptf1a (Figs. 6A, H–O), neither was there a change
in the mRNA expression of two mesenchymal markers known to play
functional roles during pancreatic development, Isl1 (Ahlgren et al.,
1997) and Wilms tumor 1 homolog (Wt1) (Wagner et al., 2005)
(Figs. 6B–C). Consistent with the above, protein levels of Isl-1, which
is also expressed in endocrine progenitors, were unaffected in S1P1
mutant pancreatic endoderm and mesenchyme (Figs. 6P–Q). We also
analyzed the expression of FGF ligand/receptor family members known
to control expansion of the pancreatic epithelium via mesenchyme-to-
epithelium signaling (Bhushan et al., 2001; Dichmann et al., 2003;
Elghazi et al., 2002; Miralles et al., 1999). However, expression of FGF10
(FGF7 could not be detected in all samples and was therefore excluded)
and its receptor FGFR2were unaffected upon S1P1 ablation (Figs. 6D–E).
Finally, the mRNA expression of two other S1P receptors, S1P2–3, which
are present in the developing pancreatic mesenchyme, showed no
compensatory up regulation of these receptors (Figs. 6F–G).
Blood vessel ablation results in increased pancreatic organ size
Our initial hypothesis evolved around the assumption that
endothelial cells, via S1P1, provide inductive signals necessary for
expansion of the pancreatic endoderm. To directly address this
hypothesis, we ablated endothelial cells in vitro using 1-[4-(6,7-
Dimethoxy-quinolin-4-yloxy)-3-ﬂuoro-phenyl]-3-(2-ﬂuoro-phenyl)-
urea (Ilovich et al., 2008), hereafter referred to as quinolin-urea, andexamined the consequences on pancreatic endoderm development.
Two days treatment with the quinolin-urea resulted in total ablation of
the blood vessels (visualized by Pecam) (Figs. 7A–B). Surprisingly,
efﬁcient ablation of endothelial cells at E11.5 did not result in
compromised expansion of the epithelium, instead, increased organ
size and hyperbranching of the pancreatic endoderm were observed
(Figs. 7A–B). Both the ventral and dorsal buds were affected, but the
effect was most striking on the ventral bud (Figs. 7C–D).
S1P1 ablation results in increased vascular density in foregut-derived
organ anlagen
The endothelial cell ablation results contradicted our initial
hypothesis and instead suggested that endothelial cells may limit
the growth of foregut-derived organs. Thus, a possible mechanism for
how S1P1 ablation may reduce endoderm organ expansion could
involve hypervascularization. Indeed, previous studies demonstrated
increased vascular density in the developing S1P1−/− limb bud (Chae
et al., 2004). Consistent with this observation, we found that S1P1
ablation results in hypervascularization (2–3-fold increase in blood
vessel density) within the mesenchyme surrounding the foregut-
derived organs, including the dorsal pancreas (Figs. 8A–C), lung
(Figs. 8D–F), stomach (Figs. 8G–I) and liver (Figs. 8J–L).
Discussion
Blood vessels are essential for the developing organism because
they provide oxygen and nutrients as well as inductive cues that
control cell proliferation and cell fate speciﬁcation during organo-
genesis. For example, blood vessels communicate with the surround-
ing tissue in the developing retina and this interplay controls both
differentiation and proliferation of blood vessels and the surrounding
astrocytes (West et al., 2005). Furthermore, endothelial cells control
the development of endoderm-derived organs, e.g. both liver and
dorsal pancreas outgrowth and early pancreatic endocrine cell
speciﬁcation (Lammert et al., 2001; Yoshitomi and Zaret, 2004).
Fig. 5. Proliferation of Pdx1+ progenitors is reduced but endocrine differentiation is unaffected in the S1P1−/− dorsal pancreas. Proliferation within the Pdx1+ epithelium was
analyzed by immunoﬂuorescence of in utero BrdU pulsed embryos. Proliferating cells markedwith BrdU (green), were found both inside the Pdx1+ epithelium (red), and outside the
mesenchyme in both S1P1 deﬁcient embryos and littermate controls (A–B). BrdU+ cells in the epithelium are indicated with ﬁlled arrowheads and in themesenchyme indicated with
open arrowheads. Scale bar 100 μm. Proliferation of Pdx1+ progenitors was signiﬁcantly reduced (35%) (Student T-test) in the S1P1 deﬁcient dorsal pancreas (littermate controls
n=7, S1P1 deﬁcient embryos n=5, p=0.0049). Red and black dots represent different litters (C). To investigate if alpha cell differentiation was affected, glucagon and Ecad volumes
of the dorsal bud were estimated by confocal microscopy. No difference between S1P1 deﬁcient embryos and littermate controls could be detected in glucagon volume divided by
Ecad volume (Student T-test, p=0.2188) (E). Note the variation within the littermate control group. Consistent with the OPT analysis a statistically signiﬁcant decrease in the
volume of the S1P1 deﬁcient dorsal pancreatic epithelium was detected with confocal microscopy (Student T-test, p=0.0014) (F). Each color of the dots represents a different litter
(littermate controls n=10, S1P1 deﬁcient embryos n=9). Representative samples are shown in D, Ecad (gray) and glucagon (green). Note the unevenly distribution of the endocrine
cells which are concentrated to the tip of the bud. Scale bar 100 μm. To analyze beta cell differentiation, the relative number of insulin+ cell (insulin volume divided by Ecad volume)
was estimated in E11.5 explants cultured for two days. No difference in the relative number of insulin+ cells in S1P1 deﬁcient embryos and littermate controls was detected (Student
T-test, p=0.2587) (H). Consistently, a statistically signiﬁcant reduction of the dorsal pancreatic epithelium volumewas observed (Student T-test, p=0.0014) (I). Littermate controls
n=6, S1P1 deﬁcient embryos n=4. Representative samples are shown in G, Ecad (gray) and insulin (green). In S1P1 deﬁcient embryos ductal organization as visualized by Mucin1
staining (red) was unaffected (J). Further analysis of cell differentiation was carried out by QPCR measurements. Expression levels of Ngn3 (K), Pax4 (L), Pax6 (M), Pdx1 (N), insulin
(O), Sox9 (P), Cpa1 (Q) and amylase (R) were measured but no statistical differences were detected. P-values; ngn3 p=0.5503, Pax4 p=3012, Pax6 p=0.6057, Pdx1 p=1456, insulin
p=0.0645, Sox9 p=0.8861, Cpa1 p=0.4472 and amylase p=0.1380.
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these endothelial signals, and whether they exclusively act in a
positive manner or play a more dynamic role by also negatively
affecting endoderm development. In this study we present evidence
in support of endothelial cells playing a hitherto unknown general
role in foregut-derived organ development by limiting growth.
Initially, the analysis of S1P1−/− mice, which show destabilized
blood vessels and hemorrhages (Liu et al., 2000), revealed a reduction
in organ size of the foregut-derived organs, including lung, liver,
stomach and pancreas. We speciﬁcally investigated the role of this
pathway in early pancreas development and now demonstrate that
S1P1 ablation results in reduced size of the dorsal and ventralpancreatic buds, but that it has no effect on endocrine or exocrine
cell fate speciﬁcation. The dorsal pancreatic bud size reduction is due
to a decrease in proliferation rate of Pdx1+ progenitors, indicating
that S1P1 is required for proliferation, but not differentiation of Pdx1+
pancreatic progenitors. The in vivo ﬁndings were reproduced in vitro,
implying that these ﬁndings do not represent indirect effects due to
the circulation phenotype of S1P1 embryos.
To verify that the requirement of S1P1 for pancreatic endoderm
expansion is mediated by endothelial cells, which is the only cell type
within the developing pancreas where S1P1 protein can be detected,
blood vessels were ablated at E11.5 in wild type gut/pancreatic
explants. Unexpectedly, removing blood vessels did not mimic the
Fig. 6.Marker expression analysis of the S1P1-deﬁcient pancreas. QPCR was used to analyze mRNA expression of genes known to be involved in development of the endoderm; Ptf1a
(A) which is known to be induced by blood vessels, as well as the mesenchymal genes Isl1 (B) and Wt1 (C) was quantiﬁed. We could not detect any statistical difference in any of
these genes. The FGF pathway including FGF10 (D) and its receptor FGFR2 (E), known to be important for the expansion of many of the endodermal organs and signiﬁcantly for the
pancreatic progenitors, were measured. In none of these genes we could detect different expression levels between S1P1 deﬁcient dorsal pancreata and littermate controls. To
investigate if S1P1 deﬁcient dorsal pancreata had an upregulation of the two other pancreatic expressed family members S1P2 (F) and S1P3 (G) we used QPCR to analyze the relative
expression levels. For S1P2 and S1P3 no upregulation was detected. S1P1+/+ littermate controls n=5, +/− littermate controls n=11, and S1P1−/− embryos n=4. Student T-test
was used; error bars represent standard error of the mean.To verify the mRNA data whole mount immunoﬂuorescence labeling of Ecad (green), Ptf1a (red) and Pdx1 (gray) was
used. Whole mount immunoﬂuorescence labeling did not reveal any altered expression levels of Ptf1a in E10.5 embryos (H–O). Neither did protein expression analysis of Isl1 and
Pdx1 on E10.5 pancreatic sections (P–Q). Scale bars 100 μm.
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endoderm expansion and hyperbranching, suggesting that endothe-
lial cells limit expansion of the pancreatic epithelium. The blood vessel
ablator, quinolin-urea, inhibits VEGFR2 and PDGFRβ (Ilovich et al.,
2008) which are expressed by the blood vessels in the pancreas
(Lammert et al., 2001). PDGFRβ is additionally also expressed in the
pancreatic mesenchyme (Hori et al., 2008). As neither of the receptors
is expressed in the pancreatic epithelium, this excludes a direct effect
of the quinolin-urea on the epithelium through these receptors. The
fact that blood vessel ablation failed to mimic the S1P1 phenotype
suggested that S1P1 is not directly involved in the reduced growth offoregut-derived organs. Alternatively, the S1P1 phenotype may be
secondarily caused by an increase in blood vessel density. In fact, this
hypothesis is in line with previous work demonstrating that S1P1-
deﬁciency results in hypervascularization in the limb bud (Chae et al.,
2004). Consistent with this, we show that S1P1 ablation results in
increased number of blood vessels in the mesenchyme that surrounds
the foregut-derived organs, including the pancreas, stomach, liver and
lung. Altogether, these observations provide evidence (both gain-of-
function and loss-of-function) in support of a model where endothelial
cells counteract growth-promoting signals – potentially mesenchyme-
derived – by providing growth-limiting signals to the pancreatic
Fig. 7. Blood vessel ablation does not mimic the S1P1 phenotype, but results in
expansion and hyperbranching of the pancreatic epithelium. Blood vessel ablation did
not mimic the phenotype seen in S1P1-deﬁcient explants (A–D). Total ablation of Pecam
(red) positive blood vessels was seen after two days of treatment with quinolin-urea
(Qu). The epithelium was visualized by Ecad (gray) (A–B). The epithelium was also
analyzed using the luminal marker Mucin1 (red). Both dorsal and ventral pancreas are
affected by the blood vessel ablation, but the hyperbranching effect is most prominent
in the ventral pancreas (C–D). Dp = dorsal pancreas and Vp = ventral pancreas. Scale
bars 100 μm.
274 F.W. Sand et al. / Developmental Biology 352 (2011) 267–277endoderm. Endothelial cell ablation experiments will have to conﬁrm
whether the samemodel applies to the other foregut-derived organs as
well.
Previously, the consequence of increased vascularization during
pancreas development has been studied by expressing VEGF under
control of the Pdx1 promoter. The over growth of blood vessels
resulted in an increase (three fold) in endocrine mass and a dramatic
decrease (seven fold) in acinar mass (Lammert et al., 2001). Although
the consequence of S1P1 deﬁciency also involves hypervasculariza-
tion, no effect on early endocrine or exocrine cell differentiation was
observed. However, the early lethality of S1P1 mutant animals
permitted the analysis of differentiation no later than E12.5. This is
at the brink of secondary transition when the variation in endocrine
differentiation between embryos is substantial, which might there-
fore, mask any difference. It is also possible that two opposing
mechanisms act in parallel in the S1P1 deﬁcient pancreas, i.e. a pro-
endocrine effect mediated by the elevated blood vessel density and a
negative effect on endocrine differentiation by the hypoxia caused by
defective blood vessels (Chae et al., 2004; Heinis et al.). Notably, the
decrease in the Pdx1+ progenitor pool in S1P1−/−mice is consistent
with the observed reduction in acinar cells in adult Pdx1-VEGF mice
(Lammert et al., 2001). Endothelial cells also play a functional role
during the earlier stages of pancreas development by initiating dorsal
pancreas formation via Ptf1a induction (Jacquemin et al., 2006;
Yoshitomi and Zaret, 2004).
In the lung, manipulation of blood vessel development has
highlighted the need for proper control of density, and spatio-
temporal distribution of the blood vessels (Akeson et al., 2003;
Schwarz et al., 2000; van Tuyl et al., 2005; Zeng et al., 1998). Taken
together it is obvious that the balance between blood vessel growth
and organ growthmust be tightly controlled. In a previous study it has
been shown that induced hypervascularization during adulthood
results in liver hyperplasia (LeCouter et al., 2003). Hypervasculariza-
tion during embryogenesis, in the S1P1 mutants, results in hypoplasia
of the liver. A possible explanation for these contrary ﬁndings could bethat different mechanisms are involved during adulthood and
embryogenesis. The inﬂuence of the blood vessels on the surrounding
tissue might also be different during different phases of development.
It is well established that the development of foregut-derived
organs, such as the pancreas, lung, stomach and liver, relies on signals
from mesenchymal and endothelial cells (Fukuda and Yasugi, 2005;
Gittes, 2009; Shannon and Hyatt, 2004; Warburton et al., 2000; Zaret,
2002, 2008). However, whether endothelial cell signals play a more
general role in development of endoderm-derived organs has so far
remained unknown. Our results show that endothelial cell hyperpla-
sia negatively inﬂuences organ development in several foregut-
derived organs, including the pancreas, stomach, lung and liver. This
suggest that endothelial cells counterbalance growth stimulatory
signals originating from other cells, such as mesenchymal cells (for a
schematic illustration see Figs. S3A–C). In the lung and stomach, blood
vessels are mainly located within the mesenchyme without direct
contact with the epithelium, whereas in the liver and pancreas, the
blood vessels are located within both the mesenchyme and the
epithelium. It is therefore probable that the molecule, which
negatively inﬂuences endodermal growth, is a blood vessel-derived
diffusible molecule or an extracellular matrix component. Future
studies will be necessary to clarify the identity and mechanism of
action of the endothelial cell-derived molecule(s) regulating organ-
ogenesis of foregut-derived organs.
Materials and methods
Animals
S1P1-deﬁcient mice were back-crossed for at least 10 generations
into C57BL6. Endoderm development was indistinguishable between
wild type and SIP1+/−mice. Genotyping of S1P1mice was performed
as previously described but with small modiﬁcations as (Liu et al.,
2000). The mice were housed in the animal facilities at the Lund
Biomedical Center, Lund University, Sweden, kept according to animal
care guidelines and all experimental procedures were approved by
the regional animal ethic committee, Lund and Malmö, Sweden.
Immunoﬂuorescence and immunoreagents
For immunoﬂuorescence, embryos, explants and whole mounts
were ﬁxed, sectioned and stained as previously described (Ahnfelt-
Ronne et al., 2007; Edsbagge et al., 2005; Esni et al., 2001; Esni et al.,
1999). Antibodies used were guinea pig anti Pdx1, 1:1000 (kind gift
from ChrisWright); rat anti Ecad, 1:400 (ECCD-2, Takara); mouse anti
Ecad, 1:100 (BD Biosciences); rat anti Pecam (CD31), 1:100 (BD
Pharmingen); goat anti Pecam (CD31), 1:500 (R&D Systems); rabbit
anti S1P1, 1:500 (Santa Cruz Biotechnology); Armenian hamster anti
Mucin1, 1:500 (Thermo Fischer Scientiﬁc); rabbit anti Ptf1a 1:2500
(BCBC, www.betacell.org/), guinea pig anti glucagon 1:500 (Linco),
guinea pig anti insulin 1:800 (Dako), rat anti CD45 1:100 (Abcam) and
rabbit anti Isl-1 1:100 (Chemicon). Nuclear staining was performed
with 4′,6-diamidino-2-phenylindole (DAPI). Proliferating cells were
detected with rat anti-BrdU, 1:200 (Nordic BioSite) 50 mg/kg BrdU
was injected intraperitoneally 2 hours (h) before the pregnant female
was sacriﬁced. Apoptosis was detected with rabbit anti Caspase 3,
1:1000 (R&D Systems). Secondary antibodies used were from
Molecular Probes and Jackson Immuno Research Laboratory Inc.
Specimens (sections, whole mounts and cultured pancreatic rudi-
ments) were analyzed using a Zeiss Axioplan microscope and an
Apotome unit or a Zeiss LSM 510 confocal microscope. The images
were processed using Adobe Photoshop and Imaris. Blood vessel
density quantiﬁcation was performed on sections throughout the
entire organ (separated by at least 50 μM) which were stained with
Pecam and E-Cadherin antibodies and DAPI. Axiovision's feather
automatic measurement was used. Total blood vessel area for
Fig. 8. S1P1 ablation results in hypervascularization. In all the investigated endodermal organs S1P1 ablation resulted in increased vascular density (A–B, D–E, G–H and I–J). The
epithelium is visualized by Ecad (green) and the blood vessels by Pecam (red). For clarity, the liver is shown both without Ecad and in insets with Ecad (I–J). Scale bar 100 μm. The
blood vessel density was quantiﬁed by measuring the blood vessel area and dividing it with the total area of the organ — the epithelial area (C, F and I). Due to the endogenous
autoﬂuorescence of the liver we used QPCR to quantify the blood vessel marker Pecam (K). In all organs we found a 2–3-fold increase in blood vessel density. P values; pancreas
p=0.0184, littermate controls n=3, and S1P1−/− embryos n=4, stomach p=0.006, littermate controls n=3, and S1P1−/− embryos n=4, lung p=0.0019, littermate controls
n=3, and S1P1−/− embryos n=3 and liver p=0.0214, littermate controls n=9, and S1P1−/− embryos n=5. d. pancreas = dorsal pancreas. Scale bar 100 μm.
275F.W. Sand et al. / Developmental Biology 352 (2011) 267–277respective organ was divided by total organ area — total epithelial
area.
Optical Projection Tomography analysis
E12.5 isolated respiratory- and gastrointestinal tracts were ﬁxed in
4% PFA for 1 h at 4 °C. Fixed tissues were washed in PBS, stepwise
dehydrated into Methanol and stored in −20 °C until used. Before
staining the tissues were rehydrated into TBST (0.15 M NaCl, 0.1 M
Tris pH 7.5, 0.1% Triton X-100) and thoroughly washed. The specimen
were blocked in blocking solution (TBST, 10% normal goat serum
(Cedar Lane Lab) and 0.01% Sodium azide (Sigma S-8032)) for 24 h at
RT, incubated with primary antibody in blocking solution for 24 h at
RT and washed extensively for 24 h in TBST. Incubation withsecondary antibody was performed as with primary antibody. The
secondary antibody solution was ﬁltered through an Acrodisc syringe
ﬁlter (Pall life sciences, 0.45 μm) to avoid precipitate induced artifacts
during OPT scanning. Tissues were washed in TBST for 24 h and
prepared for OPT scanning as previously described (Alanentalo et al.,
2007). Antibodies used were: rat anti Ecad (clone ECCD-2, Zymed) at
1:500 dilution and Alexa 594 goat anti rat (Molecular Probes) at
1:500. For the liver, endogenous autoﬂuorescence was used to deﬁne
the organ.
The specimen was scanned through 360° using the Bioptonics
3001 OPT scanner (Bioptonics) modiﬁed with an exciter D560/40X
and emitter E610lpv2 ﬁlter (Chroma) for optimal visualization of
Alexa 594 ﬂuorescence. All samples were scanned at the same
magniﬁcation. Tomographic sections (resolution: 1024×1024) of the
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Orthogonal planes were assessed using DataViewer V1.3.2 (SkyScan).
Volume renderings and isosurfaces were created using Volocity v5.3.1
(Improvision, Coventry, United Kingdom). Quantiﬁcation of organ
epithelial volumes, based on the Ecad signal, was performed using the
quantiﬁcation software module for Volocity v5.3.1. The original image
stacks of GI tract epitheliumweremanually cropped into lung, stomach,
ventral pancreas and dorsal pancreas. A “ﬁnd objects by intensity” task
was applied to select voxels according to a speciﬁed intensity threshold
value. The value was chosen to exclude pixels not contributing the
labeled objects (the organ epithelium). A ﬁne ﬁlter (3×3 kernel) was
also applied to the data sets to avoid selection of background noise
voxels with intensities above the threshold level. The volumes of the
measured objects were ﬁnally exported to the Excel 2007 (Microsoft
Corporation, Redmond, Washington) software for statistical analysis.
Culture of pancreatic rudiments
Isolation, recombination, and culture of pancreatic rudimentswere
carried out essentially as previously described (Ahlgren et al., 1996;
Esni et al., 2001; Gittes and Galante, 1993). The explants were
cultured from 48 h up to six days in a humidiﬁed incubator of 37 °C
with 5% CO2. Only S1P1-deﬁcient embryos of similar size as their wild
type littermates with no apparent external morphological changes,
except for shorter limbs and tail and hemorrhages, were chosen for
analysis. For the blood vessel ablation experiments, quinolin-urea was
added to the culture medium (0.5 μM) at day one of culture.
Quantitative real-time PCR
Dorsal buds from E10.5 or E12.5 embryos were dissected and
directly frozen in lysis buffer. Total RNA was extracted with
QIAshredder together with RNeasy Micro Kit (Qiagen) according to
the manufacturer's instructions. Reverse transcription was performed
in 10 μL reactions with SuperScript III (Invitrogen) according to the
manufacturer's instruction using a mixture of 2.5 μM oligo(dT) and
random hexamers (Invitrogen). All samples were diluted to 200 μL
with water prior to real-time PCR. Real-time PCR measurements were
performed on a LightCycler 480 (Roche Diagnostics). 10 μL reactions
contained 10 mM Tris (pH 8.3), 50 mM KCl, 3 mM MgCl2, 0.3 mM
dNTP, 1 U JumpStart Taq Polymerase (all Sigma-Aldrich), 0.25 X SYBR
Green I (Invitrogen), 400 nM of each primer (Invitrogen) and 2 μL
cDNA. Primer sequences are available as supplementary data (Fig. S5).
Actb and B2m were measured using primers contained in the Mouse
Endogenous Control Panel supplied by TATAA Biocenter. All samples
were run as duplicates. Formation of expected PCR products was
conﬁrmed by agarose gel electrophoresis and melting curve analysis
for all samples. Gene expression data was normalized against the
geometric average of Actb and B2m and data analysis was performed
as described (Nolan et al., 2006; Stahlberg et al., 2008).
For E12.5 samples StepOnePLUS Real Time PCR system from
Applied Biosystems was used. The samples were normalized against
HPRT and not run in duplicates.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.01.026.
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